Stay updated with breaking news from Amarillo Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mifepristone is used in abortions — including medical abortions and treatments for miscarriage — but conflicting opinions issued by two federal judges could mean the Supreme Court may need to step in to determine whether people will still have access to the drug, which was approved by the FDA more than 20 years ago.
The Department of Labor challenged the plaintiffs’ standing and defended the legality of the new ESG rule, but saw its motion for a venue change dismissed.
[This is part four of a series on the first-of-its-kind federal lawsuit, Americans for Hippocratic Medicine v. U.S. Food and Drug Administration, in which doctors and medical practitioners are asking the courts to hold the FDA accountable for its reckless and illegal approval of dangerous chemical abortion drugs.]
The past year has seen a new star become fixed in the judicial firmament. The US District Court for the Northern District of Texas, Amarillo Division, has found new prominence, most...